August Moretti
2019
In 2019, August Moretti earned a total compensation of $2.1M as Chief Financial Officer at 4D Molecular Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $89,725 |
|---|---|
| Option Awards | $1,661,243 |
| Salary | $374,242 |
| Other | $12,500 |
| Total | $2,137,710 |
Moretti received $1.7M in option awards, accounting for 78% of the total pay in 2019.
Moretti also received $89.7K in non-equity incentive plan, $374.2K in salary and $12.5K in other compensation.
Rankings
In 2019, August Moretti's compensation ranked 5,581st out of 13,971 executives tracked by ExecPay. In other words, Moretti earned more than 60.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,581 out of 13,971 | 60th |
Division Manufacturing | 2,089 out of 5,701 | 63rd |
Major group Chemicals And Allied Products | 744 out of 2,200 | 66th |
Industry group Drugs | 624 out of 1,886 | 67th |
Industry Biological Products, Except Diagnostic Substances | 151 out of 389 | 61st |
Source: SEC filing on April 6, 2021.
Moretti's colleagues
We found one more compensation record of an executive who worked with August Moretti at 4D Molecular Therapeutics in 2019.
2019
David Kirn
4D Molecular Therapeutics